The world first started to hear about a novel coronavirus in early January 2020, with reports of an alleged new pneumonia-like illness spreading across Wuhan, China.
The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.
Former Pfizer VP Michael Yeadon maintains that since the infection fatality ratio of COVID-19 has not been high, the vaccines should not have been mandated.
The U.S. Food and Drug Administration’s (FDA) top vaccine official told a congressional committee on Friday that COVID-19 vaccines for kids under 6 will not have to meet the agency’s 50% efficacy threshold required to obtain Emergency Use Authorization (EUA).